SCHEMBL514083

SCHEMBL514083

FCC=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513947 0.67
SCHEMBL2812597 0.59
SCHEMBL8844029 0.59
SCHEMBL16732706 0.59
SCHEMBL38028 0.59
SCHEMBL499144 0.59
SCHEMBL10402099 0.56
SCHEMBL73273 0.56
SCHEMBL103776 0.56
SCHEMBL17890374 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3151836-A2 COMPOSITION COMPRISING CYCLODEXTRIN AND BUDESONIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF PULMONARY INFLAMMATIONS Université de Liège (BE) 2017-04-12 EP claimed
US-20160051568-A1 CYCLODEXTRIN AND BUDESONIDE DERIVATIVE COMPOSITIONS AND METHODS MAES PAUL (BE) 2016-02-25 US claimed
EP-2923702-A1 Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease Universite De Liege (BE) 2015-09-30 EP claimed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
EP-4122469-A1 COMPOSITION COMPRISING CYCLODEXTRIN AND BUDESONIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF PULMONARY INFLAMMATIONS Maes, Paul (BE) 2023-01-25 EP disclosed
CN-106413759-B Composition comprising cyclodextrin and budesonide derivatives for the treatment and prevention of pulmonary inflammation 列日大学 2022-02-22 CN disclosed
CN-113144215-A Composition comprising cyclodextrin and budesonide derivatives for the treatment and prevention of pulmonary inflammation 列日大学 2021-07-23 CN disclosed
US-9993487-B2 Cyclodextrin and budesonide derivative compositions and methods UNIV LIEGE (BE) 2018-06-12 US disclosed
EP-3151836-A2 COMPOSITION COMPRISING CYCLODEXTRIN AND BUDESONIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF PULMONARY INFLAMMATIONS Université de Liège (BE) 2017-04-12 EP disclosed
US-20160369294-A9 NUCLEOTIDE SEQUENCES AND CORRESPONDING POLYPEPTIDES CONFERRING MODIFIED PHENOTYPE CHARACTERISTICS IN PLANTS CERES, INC. (US) 2016-12-22 US disclosed
US-20160051568-A1 CYCLODEXTRIN AND BUDESONIDE DERIVATIVE COMPOSITIONS AND METHODS MAES PAUL (BE) 2016-02-25 US disclosed
EP-1076656-A2 N-HETEROARYL-SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES Novartis AG (CH) 2001-02-21 EP disclosed
WO-1999055693-A2 N-HETEROARYL-SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES NOVARTIS AG (CH) 1999-11-04 WO disclosed
EP-0839808-A1 Pyrazole derivatives, processes for their preparation, and their use as herbicides Novartis AG (CH) 1998-05-06 EP disclosed
EP-0277194-B1 OLEFIN OLIGOMERIZATION PROCESS AND CATALYST CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1992-01-02 EP disclosed
EP-0277194-A4 OLEFIN OLIGOMERIZATION PROCESS AND CATALYST. CHEVRON RES (US) 1988-11-23 EP disclosed
EP-0277194-A1 OLEFIN OLIGOMERIZATION PROCESS AND CATALYST. CHEVRON RES (US) 1988-08-10 EP disclosed
US-4757042-A Complex of nickel and palladium with fluoroorganic thiol or sulfide ligand and borohydride or organoaluminum halide or alkoxide CHEVRON RESEARCH COMPANY (US) 1988-07-12 US disclosed
WO-1988001261-A1 OLEFIN OLIGOMERIZATION PROCESS AND CATALYST CHEVRON RESEARCH COMPANY (US) 1988-02-25 WO disclosed
US-4677241-A USING TRANSITION METAL COMPLEX CATALYST AND ORGANOMETALLIC REDUCING AGENT CHEVRON RESEARCH COMPANY (US) 1987-06-30 US disclosed